The US drug regulator had inspected Alembic Pharma#39;s oncology formulations (injectable and oral solid) unit at Panelav in Gujarat from February 28 to March 8
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Leave a Comment